ARCAID allows us to bring together 20 of the most talented young researchers in biomedicine from all over the world with top translational scientists.
Biomarkers that predict immunotherapy treatment success or risk of toxicity are urgently needed, to increase clinical benefit of metastatic melanoma patients.
The objective of Immune-Image is to develop a novel non-invasive imaging strategy for assessing immune cell activation and dynamics.
Chronic symptoms attributed to Lyme borreliosis can be challenging to diagnose and treat. This state of the art and systematic review in the BMJ by Kullberg and collaborators offers a roadmap for physicians how to provide the best possible and personalised care for their patients.
The adequacy of currently used dosing regimens of ciprofloxacin and ceftazidime are explored and if required improved.
Isolation of 403 monoclonal antibodies from COVID-19 patients revealed convergent gene usage and multiple target epitopes
MS is characterized by inflammatory attacks of infiltrating leukocytes at onset but evolves into a progressive disease within the central nervous system.
Current immunotherapies only benefit a minority of cancer patients. We need new approaches to boost patients’ anti-tumor immune responses.
Camelid-derived single domain antibodies (VHH)5 specific for the human MHC class I-like molecule CD1d can modulate the function of CD1d-restricted T cell populations.
The lab of Jan Van den Bossche investigates how metabolism controls macrophages and disease progression.
The TREAT NL registry is a national registry of children and adults with moderate-to-severe atopic eczema (AE).
Urinary tract infection (UTI) is one of the most common infections for which antimicrobials are prescribed. In the event of asymptomatic bacteriuria (ASB), antimicrobial prescriptions are not always necessary. The aim of this project is to reduce the overtreatment of ASB by using a multifaceted de-implementation strategy.